Comprehensive Weight Control Center, Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.
Expert Rev Endocrinol Metab. 2022 Sep;17(5):405-414. doi: 10.1080/17446651.2022.2101993. Epub 2022 Jul 31.
Bariatric surgery is the most effective intervention currently available for significant and durable weight loss, but weight regain after surgery is not uncommon. This paper focuses on updates in behavioral interventions and pharmacotherapy to combat weight regain after bariatric surgery.
This paper critically reviews both prospective and retrospective studies assessing pharmacotherapy in post-bariatric surgical patients published within the past 5 years. It also evaluates updates in behavioral therapies and delivery of the therapies in this patient population.
Weight regain after bariatric surgery is common. Patients who experience weight regain should be evaluated and treated by a multidisciplinary team. Antiobesity pharmacotherapy should be considered for those who qualify as an adjunct to lifestyle modifications, along with behavioral interventions such as cognitive behavioral therapy.
减重手术是目前治疗显著和持久减重最有效的干预手段,但手术后体重反弹并不少见。本文重点介绍了减重手术后对抗体重反弹的行为干预和药物治疗的最新进展。
本文批判性地回顾了过去 5 年内发表的评估减重手术后患者药物治疗的前瞻性和回顾性研究。它还评估了该患者人群中行为疗法的更新和治疗方法。
减重手术后体重反弹很常见。经历体重反弹的患者应通过多学科团队进行评估和治疗。对于符合生活方式改变辅助治疗标准的患者,应考虑使用抗肥胖药物治疗,并结合认知行为疗法等行为干预措施。